<DOC>
	<DOCNO>NCT01711788</DOCNO>
	<brief_summary>The purpose study determine method intrabone infusion hematologic stem cell increase accelerate hematopoietic reconstitution umbilical cord blood transplantation pediatric patient .</brief_summary>
	<brief_title>Intrabone Infusion Umbilical Cord Blood Stem Cells</brief_title>
	<detailed_description>Umbilical cord blood transplantation ( UCBT ) increasingly use treat malignant non-malignant haematological , immunodeficiency metabolic disease . UCBT offer advantage easy procurement , risk donor , reduce risk transmit infection , immediate availability cryopreserved unit , acceptable partial HLA mismatch . However , patient treat UCBT show delay hematopoietic immunological recovery , high rate infection , relapse original malignant disease , lead life threaten problem . UCBT also result high rate graft failure compare hematopoietic stem cell transplantation ( HSCT ) source . The problem slow hematopoietic recovery post-UCBT address use number different approach adult patients.In adult , use intrabone injection cord blood result faster hematopoietic recovery phase II study . However , clinical trial pediatric patient . This study address determine change cord blood stem cell infusion method increase accelerate hematopoietic reconstitution UCBT pediatric patient .</detailed_description>
	<criteria>One 21 year age ; More 10 kg weight ; Diagnosis hematopoietic disorder ( malignant ) indication hematopoietic stem cell transplantation ; Absence HLAidentical relate donor ; Availability single cord blood ( CB ) least 3 x 10^7 nucleated cell ( NCs ) /kg ( HLA identical 1 HLAmismatch ) least 4 x 10^7 NCs/kg ( 2 HLAmismatch ) freezing . Use two CB unit ( `` double cord transplant '' ) allow provide : 1 ) single CB unit fulfil criterion available ; 2 ) maximum 2 HLA mismatch present CB unit ; 3 ) minimum 4 x 10^7 NCs/kg ( sum CB unit ) present freezing . A myeloablativeconditioning regimen ; A Lansky ( patient less 16 year age ) Karnofsky ( patient 16 year age ) score equal high 70 % . Adequate organ function follow : Cardiac ( ejection fraction &gt; 50 % ) ; Renal ( serum creatinine within normal range age , creatinine clearance GFR &gt; 70 ml/min/1.73m2 ) ; Hepatic ( AST ALT &lt; 5 x upper limit normal age ) ; Pulmonary ( FEV1 , FVC , DLCO â‰¥ 50 % pulmonary function test , child unable cooperate , sign dyspnea rest , exercise intolerance , supplementary oxygen therapy , normal pulmonary radiography pulmonary scan ) ; No sign uncontrolled systemic bacterial , fungal viral infection ; Written inform consent patient his/her legal guardian Nonmyeloablative conditioning ; Pregnancy breastfeeding ; HIV positive serology ; Bone disease ( e.g . osteopetrosis , osteogenesis imperfecta ) Previous autologous allogeneic hematopoietic stem cell transplantation perform one year enrolment , except case nonengraftment early rejection previous allogeneic stem cell transplantation . Active skin infection site intrabone injection . History intolerance/allergy sedation medication local anesthetic . Contraindication sedation</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Hematopoietic stem cell</keyword>
	<keyword>Umbilical cord blood transplantation</keyword>
	<keyword>Intrabone infusion</keyword>
	<keyword>Platelet recovery</keyword>
	<keyword>Neutrophil recovery</keyword>
	<keyword>Pediatric patient</keyword>
</DOC>